0001493152-23-029445.txt : 20230818
0001493152-23-029445.hdr.sgml : 20230818
20230818162149
ACCESSION NUMBER: 0001493152-23-029445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230817
FILED AS OF DATE: 20230818
DATE AS OF CHANGE: 20230818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rivard Paul
CENTRAL INDEX KEY: 0001857479
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 231186121
MAIL ADDRESS:
STREET 1: C/O AKERS BIOSCIENCES, INC.
STREET 2: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 623
CITY: BALTIMORE
STATE: MD
ZIP: 21205
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 623
CITY: BALTIMORE
STATE: MD
ZIP: 21205
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences, Inc.
DATE OF NAME CHANGE: 20170413
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
4
1
ownership.xml
X0508
4
2023-08-17
0
0001321834
MyMD Pharmaceuticals, Inc.
MYMD
0001857479
Rivard Paul
855 N. WOLFE STREET,
SUITE 601
BALTIMORE
MD
21205
0
1
0
0
Chief Legal Officer
0
Common stock
2023-08-17
4
P
0
25000
1.1232
A
250000
D
/s/ Paul Rivard
2023-08-18